| mRNA |
ATRA |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-08 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-06 |
| mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
| mRNA |
VX-680 |
CTRPv2 |
pan-cancer |
AAC |
0.38 |
0.0002 |
| mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0007 |
| mRNA |
PHA-793887 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0009 |
| mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.001 |
| mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |